Merck KGaA/MRK

€152.95

0.16%
-
1D1W1MYTD1YMAX

About Merck KGaA

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Ticker

MRK

Sector

Healthcare

Trading on

XETRA

Industry

Biotechnology & Drugs

CEO

Belen Garijo

Employees

62,908

Headquarters

Darmstadt, Germany

Merck KGaA Metrics

BasicAdvanced
€66.78B
Market cap
23.65
P/E ratio
€6.50
EPS
0.66
Beta
€2.20
Dividend rate
1.43%
Dividend yield
€66.78B
0.66417
€172.40
€134.30
287.82K
€2.20
1.425
0.892
34.63
36.973
10.05%
32.166
32.81%
5.84%
10.74%
7.2%
23.646
3.181
2.503
29.252
45.215
1.12%
1.43%
1.43%
-5.57%
-14.97%
6.19%
12.43%
16.26%

What the Analysts think about Merck KGaA

Analyst Ratings

Majority rating from 20 analysts.
Buy

Price Targets

Average projection from 17 analysts.
18.73% upside
High €210.00
Low €155.00
€152.95
Current price
€181.59
Average price target

Merck KGaA Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
11.21% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
€5.23B
1.01%
Net income
€586M
-20.6%
Profit margin
11.21%
-21.39%

Merck KGaA Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 3.28%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
€2.36
€2.20
€2.07
€1.85
-
Expected
€2.38
€2.19
€1.99
€1.91
€1.98
Surprise
-0.85%
0.43%
3.91%
-3.28%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Deutsche Börse. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Merck KGaA stock?

Merck KGaA (MRK) has a market cap of €66.78B as of April 13, 2024.

What is the P/E ratio for Merck KGaA stock?

The price to earnings (P/E) ratio for Merck KGaA (MRK) stock is 23.65 as of April 13, 2024.

Does Merck KGaA stock pay dividends?

Yes, the Merck KGaA (MRK) stock pays dividends to shareholders. As of April 13, 2024, the dividend rate is €2.2 and the yield is 1.43%. Merck KGaA has a payout ratio of 10.05% on a trailing twelve-month basis.

When is the next Merck KGaA dividend payment date?

The next Merck KGaA (MRK) dividend payment is scheduled for May 02, 2024.

What is the beta indicator for Merck KGaA?

Merck KGaA (MRK) has a beta rating of 0.66. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Merck KGaA stock price target?

The target price for Merck KGaA (MRK) stock is €181.59, which is 18.73% above the current price of €152.95. This is an average based on projections from 17 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Merck KGaA stock

Buy or sell Merck KGaA stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing